Understanding surrogate outcomes in cancer screening research trials
Cancer Research UK event gives insight into UK NSC position on use of surrogate outcomes in cancer screening trials.
The UK National Screening Committee Secretariat team supports the independent scientific committee in carrying out its work. Based within the Department of Health and Social Care, the team manages the committee’s governance, evidence review programme, stakeholder engagement, public consultations and communications. It commissions and oversees evidence reviews, coordinates committee and expert group meetings, develops workplans, supports decision-making processes, and helps make sure UK NSC recommendations are evidence-based and transparent.
Cancer Research UK event gives insight into UK NSC position on use of surrogate outcomes in cancer screening trials.
The in-service evaluation of newborn screening for spinal muscular atrophy is under way in NHS services in England.
There is just one week left to apply for one of the 4 expert roles on the UK National Screening Committee.
The modelling study that informed the UK NSC's updated prostate cancer screening recommendation will be maintained for a further 3 years.
The UK NSC has announced 2 new dates for its screening masterclass: Friday 4 September and Monday 7 December.
The government has issued a call to collaborate to seek additional funding to extend the evaluation of newborn screening for SMA to all the English screening laboratories.
The UK NSC has opened a public consultation on screening for osteoporosis in women.
The UK National Screening Committee (UK NSC) advises ministers and the NHS in the 4 UK countries about all aspects of population screening and supports implementation of
screening programmes.
Recent Comments